Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stag... von Gauler, T.C., Besse, B., Mauguen, A., Meric, J.B., Gounant, V., Fischer, B., Overbeck, T.R., Krissel, H., Laurent, D., Tiainen, M., Commo, F., Soria, J.C., Eberhardt, W.E.E.

Volltext

Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial von Assi, H, Missenard, G, Terrier, P, Le Pechoux, C, Bonvalot, S, Vanel, D, Meric, J B, Tursz, T, Lecesne, A

Volltext

C1-01: Phase II open-label study to investigate PTK787/ZK 222584 (PTK/ZK) orally administered as a second-line monotherapy in patients with stage IIIB or stage IV non-small-cell lu... von Gauler, T.C., Besse, B, Meric, J.B., Gounant, V, Fischer, B, Overbeck, T, Krissel, H, Laurent, D, Soria, J.C., Eberhardt, W.E.E.

Volltext

Outcome after combined modality treatment for primary adenocarcinoma of the anal canal: a rare cancer network multicenter study von Belkacémi, Y., Berger, C., Poortmans, P., Zouhair, A., Méric, J.B., Piel, G., Nguyen, T.D., Krengli, M., Behrensmeier, F., Touboul, E.

Volltext

Cataracte radio-induite : aspects physiopathologiques, radiobiologiques et cliniques von Belkacémi, Y., Touboul, E., Méric, J.B., Rat, P., Warnet, J.M.

Volltext

170 Novel, ultra-deep next-generation sequencing for BRAF mutation testing using small amount of cell-free DNA from plasma of patients with advanced cancers von Janku, F, Huang, H.J, Ramzanali, N.M, Cai, X, Klausner, R, Meric-Bernstam, F, Fan, J.B

Volltext

CO-27 – Toxoplasmose congénitale: comparaison randomisée de stratégies de prévention des rétinochoroïdites von Javerliac, V., Binquet, C., Cornu, C., Wallon, M., Dureau, P., Genevois, O., Milazzo, S., Benzerroug, M., Garcia Meric, P., Peyron, F., Bonin, A., Villena, I., Gouyon, J.B., Kieffer, F.

Volltext